Targeting hepatic glutaminase activity to ameliorate hyperglycemia
Nature Medicine2018Vol. 24(4), pp. 518–524
Citations Over TimeTop 10% of 2018 papers
Russell Miller, Yuji Shi, Wenyun Lu, David Pirman, Aditi Jatkar, Matthew Blatnik, Hong Wu, César Cárdenas, Min Wan, J. Kevin Foskett, Junyoung O. Park, Yiyi Zhang, William L. Holland, Joshua D. Rabinowitz, Morris J. Birnbaum
Related Papers
- → Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies(2020)177 cited
- → Glutaminase inhibition as potential cancer therapeutics: current status and future applications(2023)27 cited
- → Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839(2014)7 cited
- → Glutaminase expression is correlated with adverse clinicopathological features and patient outcome in endometrial cancer(2020)2 cited
- → Faculty Opinions recommendation of c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.(2009)